Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Cirrhosis

  Free Subscription


Articles published in J Gastroenterol Hepatol

Retrieve available abstracts of 80 articles:
HTML format
Text format



Single Articles


    March 2017
  1. HSIEH YC, Lee KC, Chen PH, Su CW, et al
    Acute kidney injury predicts mortality in cirrhotic patients with gastric variceal bleeding.
    J Gastroenterol Hepatol. 2017 Mar 8. doi: 10.1111/jgh.13777.
    PubMed     Text format     Abstract available


    January 2017
  2. SEKI A, Ikeda F, Miyatake H, Takaguchi K, et al
    Risk of secondary osteoporosis due to lobular cholestasis in non-cirrhotic primary biliary cholangitis.
    J Gastroenterol Hepatol. 2017 Jan 23. doi: 10.1111/jgh.13746.
    PubMed     Text format     Abstract available


  3. WANG Y, Huang W, Li R, Yun Z, et al
    Systematic Quantitation of Histologic Patterns Shows Accuracy in Reflecting Cirrhotic Remodeling.
    J Gastroenterol Hepatol. 2017 Jan 9. doi: 10.1111/jgh.13722.
    PubMed     Text format     Abstract available


    December 2016
  4. CHETCUTI ZAMMIT S, Chircop A, Cortis K, Pullicino E, et al
    Hepatobiliary and Pancreatic: Congenital intrahepatic portosystemic venous shunting: A great mimicker of liver cirrhosis.
    J Gastroenterol Hepatol. 2016;31:1917.
    PubMed     Text format    


    November 2016
  5. BUSK TM, Moller S, Pedersen EB, Gerbes A, et al
    Aquaporin-2 Excretion in Hospitalized Patients with Cirrhosis: Relation to Development of Renal Insufficiency and Mortality.
    J Gastroenterol Hepatol. 2016 Nov 7. doi: 10.1111/jgh.13641.
    PubMed     Text format     Abstract available


    August 2016
  6. MORIO K, Imamura M, Kawakami Y, Morio R, et al
    Real-World Efficacy and Safety of Daclatasvir and Asunaprevir Therapy for Hepatitis C Virus-Infected Cirrhosis Patients.
    J Gastroenterol Hepatol. 2016 Aug 11. doi: 10.1111/jgh.13511.
    PubMed     Text format     Abstract available


    July 2016
  7. HURRY PK, Poulsen JH, Bendtsen F, Moller S, et al
    Neutrophil gelatinase associated lipocalin and Cystatin C in cirrhosis and portal hypertension: Relations to organ extraction and dysfunction.
    J Gastroenterol Hepatol. 2016 Jul 20. doi: 10.1111/jgh.13492.
    PubMed     Text format     Abstract available


  8. LEBRETON A, Sinegre T, Pereira B, Lamblin G, et al
    Plasma hypercoagulability in the presence of thrombomodulin but not of activated protein C in patients with cirrhosis.
    J Gastroenterol Hepatol. 2016 Jul 15. doi: 10.1111/jgh.13493.
    PubMed     Text format     Abstract available


    June 2016
  9. LIANG XE, Zhong C, Huang L, Yang S, et al
    Stepwise Application of Transient Elastography and Routine Biomarkers Optimizes Hepatitis B Cirrhosis Detection.
    J Gastroenterol Hepatol. 2016 Jun 26. doi: 10.1111/jgh.13475.
    PubMed     Text format     Abstract available


    May 2016
  10. CHOLONGITAS E, Ioannidou M, Goulis I, Chalevas P, et al
    Comparison of Creatinine and Cystatin Formulae with 51 Chromium-Edta Glomerular Filtration Rate in Patients With Decompensated Cirrhosis.
    J Gastroenterol Hepatol. 2016 May 13. doi: 10.1111/jgh.13446.
    PubMed     Text format     Abstract available


  11. PATERNOSTRO R, Reiberger T, Mandorfer M, Schwarzer R, et al
    Plasma renin concentration represents an independent risk factor for mortality and is associated with liver dysfunction in patients with cirrhosis.
    J Gastroenterol Hepatol. 2016 May 10. doi: 10.1111/jgh.13439.
    PubMed     Text format     Abstract available


  12. KUTTING F, Schubert J, Franklin J, Bowe A, et al
    Insufficient evidence of benefit regarding mortality due to albumin substitution in HCC-free cirrhotic patients undergoing large volume paracentesis.
    J Gastroenterol Hepatol. 2016 May 3. doi: 10.1111/jgh.13421.
    PubMed     Text format     Abstract available


    April 2016
  13. K YADAV S, Goel A, A Saraswat V, A Thomas M, et al
    Evaluation of Cognitivity, Proinflammatory Cytokines, and Brain MRI in Minimal Hepatic Encephalopathy induced by Cirrhosis and EHPVO.
    J Gastroenterol Hepatol. 2016 Apr 27. doi: 10.1111/jgh.13427.
    PubMed     Text format     Abstract available


  14. CHIEN J, Liu J, Lee MH, Jen CL, et al
    Risk and Predictors of Hepatocellular Carcinoma for Chronic Hepatitis b Patients With Newly Developed Cirrhosis.
    J Gastroenterol Hepatol. 2016 Apr 26. doi: 10.1111/jgh.13422.
    PubMed     Text format     Abstract available


  15. SHEPTULINA A, Shirokova E, Nekrasova T, Blum H, et al
    Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis.
    J Gastroenterol Hepatol. 2016 Apr 5. doi: 10.1111/jgh.13407.
    PubMed     Text format     Abstract available


    March 2016
  16. KAO JH, Tung SY, Lee Y, Thongsawat S, et al
    Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis.
    J Gastroenterol Hepatol. 2016 Mar 19. doi: 10.1111/jgh.13374.
    PubMed     Text format     Abstract available


    February 2016
  17. FRIEDRICH K, Smit M, Wannhoff A, Rupp C, et al
    Coffee consumption protects against progression in liver cirrhosis and increases long-term survival after liver transplantation.
    J Gastroenterol Hepatol. 2016 Feb 15. doi: 10.1111/jgh.13319.
    PubMed     Text format     Abstract available


  18. LIU H, Liu J, Zhang Y, Liao J, et al
    Contrast-enhanced ultrasound and CT perfusion imaging of a liver fibrosis-early cirrhosis in dogs.
    J Gastroenterol Hepatol. 2016 Feb 15. doi: 10.1111/jgh.13320.
    PubMed     Text format     Abstract available


  19. PELUCCHI S, Galimberti S, Greni F, Rametta R, et al
    Proprotein convertase 7 rs236918 is associated with liver fibrosis in Italian patients with HFE-related Hemochromatosis.
    J Gastroenterol Hepatol. 2016 Feb 11. doi: 10.1111/jgh.13315.
    PubMed     Text format     Abstract available


  20. HALABI SA, Sawas T, Sadat B, Jandali A, et al
    Early TIPS Versus Endoscopic Therapy for Secondary Prophylaxis After Management of Acute Esophageal Variceal Bleeding in Cirrhotic Patients: A Meta-Analysis of Randomized Controlled Trials.
    J Gastroenterol Hepatol. 2016 Feb 9. doi: 10.1111/jgh.13303.
    PubMed     Text format     Abstract available


    December 2015
  21. SINGH J, Sharma BC, Maharshi S, Puri V, et al
    Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    J Gastroenterol Hepatol. 2015 Dec 30. doi: 10.1111/jgh.13283.
    PubMed     Text format     Abstract available


  22. QIN B, Wei T, Wang L, Ma N, et al
    Decreased expression of TIPE2 contributes to the hyper-reactivity of monocyte to TLR ligands in primary biliary cirrhosis.
    J Gastroenterol Hepatol. 2015 Dec 8. doi: 10.1111/jgh.13251.
    PubMed     Text format     Abstract available


  23. GAETANO JN, Micic D, Aronsohn A, Reddy G, et al
    The benefit of paracentesis on hospitalized adults with cirrhosis and ascites.
    J Gastroenterol Hepatol. 2015 Dec 8. doi: 10.1111/jgh.13255.
    PubMed     Text format     Abstract available


    November 2015
  24. MAIWALL R, Kumar S, Sharma MK, Wani Z, et al
    Prevalence and prognostic significance of hyperkalemia in hospitalized patients with cirrhosis.
    J Gastroenterol Hepatol. 2015 Nov 24. doi: 10.1111/jgh.13243.
    PubMed     Text format     Abstract available


    October 2015
  25. BALDUCCI G, Sterpetti AV, Ventura M
    A short history of portal hypertension and of its management.
    J Gastroenterol Hepatol. 2015 Oct 29. doi: 10.1111/jgh.13200.
    PubMed     Text format     Abstract available


  26. ZHANG F, Duan X, Zhang M, Li Z, et al
    Influence of CYP2D6 and beta2-adrenergic receptor gene polymorphisms on the hemodynamic response to propranolol in Chinese Han patients with cirrhosis.
    J Gastroenterol Hepatol. 2015 Oct 21. doi: 10.1111/jgh.13198.
    PubMed     Text format     Abstract available


  27. WANG D, Wang Q, Yin J, Dong R, et al
    Combined administration of propranolol plus AG490 offers better effects on portal hypertensive rats with cirrhosis.
    J Gastroenterol Hepatol. 2015 Oct 21. doi: 10.1111/jgh.13207.
    PubMed     Text format     Abstract available


    September 2015
  28. CARIAS S, Castellanos AL, Vilchez V, Nair R, et al
    Non-alcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.
    J Gastroenterol Hepatol. 2015 Sep 23. doi: 10.1111/jgh.13166.
    PubMed     Text format     Abstract available


  29. LIN SY, Wang YY, Chuang YH, Chen CJ, et al
    Skeletal muscle proteolysis is associated with sympathetic activation and TNF-alpha-ubiquitin-proteasome pathway in liver cirrhotic rats.
    J Gastroenterol Hepatol. 2015 Sep 23. doi: 10.1111/jgh.13159.
    PubMed     Text format     Abstract available


    August 2015
  30. MORGAN ML, Sigala B, Soeda J, Cordero P, et al
    Acetylcholine induces fibrogenic effects via M2/M3 ACh receptors in NASH and in primary human hepatic stellate cells.
    J Gastroenterol Hepatol. 2015 Aug 13. doi: 10.1111/jgh.13085.
    PubMed     Text format     Abstract available


  31. BAO Q, Wang B, Yu L, Weng H, et al
    A modified prognostic score for critically ill patients with cirrhosis: an observational study.
    J Gastroenterol Hepatol. 2015 Aug 7. doi: 10.1111/jgh.13076.
    PubMed     Text format     Abstract available


  32. TU T, Calabro SR, Lee A, Maczurek AE, et al
    Hepatocytes in liver injury: victim, bystander, or accomplice in progressive fibrosis?
    J Gastroenterol Hepatol. 2015 Aug 4. doi: 10.1111/jgh.13065.
    PubMed     Text format     Abstract available


    July 2015
  33. SANTOS LA, Lima TB, Augusti L, de Campos Franzoni L, et al
    Handgrip strength as a predictor of bone mineral density in cirrhotic outpatients.
    J Gastroenterol Hepatol. 2015 Jul 25. doi: 10.1111/jgh.13062.
    PubMed     Text format     Abstract available


  34. ZHANG CX, Xu JM, Li JB, Kong DR, et al
    Predict esophageal varices via routine trans-abdominal ultrasound: A design of classification analysis model.
    J Gastroenterol Hepatol. 2015 Jul 21. doi: 10.1111/jgh.13045.
    PubMed     Text format     Abstract available


  35. SEO JH, Song MJ
    Complete Remission after Hepatic Arterial Infusion Chemotherapy for advanced Hepatocellular carcinoma with decompensated cirrhosis.
    J Gastroenterol Hepatol. 2015 Jul 15. doi: 10.1111/jgh.13033.
    PubMed     Text format    


  36. KUMAR S
    Hepatology: De novo primary sclerosing cholangitis post liver transplantation.
    J Gastroenterol Hepatol. 2015;30:1114.
    PubMed     Text format    


    June 2015
  37. SHIN SK, Kim JH, Park H, Kwon OS, et al
    Improvement of liver function and non-invasive fibrosis markers in hepatitis B virus-associated cirrhosis: 2 years of entecavir treatment.
    J Gastroenterol Hepatol. 2015 Jun 11. doi: 10.1111/jgh.13020.
    PubMed     Text format     Abstract available


  38. OGAWA E, Furusyo N, Kajiwara E, Nomura H, et al
    Comparative effectiveness and safety study of triple therapy with simeprevir or telaprevir for non-cirrhotic patients with chronic hepatitis C virus genotype 1b infection.
    J Gastroenterol Hepatol. 2015 Jun 11. doi: 10.1111/jgh.13016.
    PubMed     Text format     Abstract available


    May 2015
  39. MAHARSHI S, Sharma BC, Srivastava S
    Malnutrition in Cirrhosis Increases Morbidity and Mortality.
    J Gastroenterol Hepatol. 2015 May 14. doi: 10.1111/jgh.12999.
    PubMed     Text format     Abstract available


  40. LIN JS, Zhou L, Sagayaraj A, Jumat NH, et al
    Hepatic differentiation of Human Amniotic Epithelial cells and in vivo therapeutic effect on animal model of cirrhosis.
    J Gastroenterol Hepatol. 2015 May 14. doi: 10.1111/jgh.12991.
    PubMed     Text format     Abstract available


  41. YOU SC, Kim KJ, Kim SU, Kim BK, et al
    Hepatic fibrosis assessed using transient elastography is independently associated with coronary artery calcification.
    J Gastroenterol Hepatol. 2015 May 14. doi: 10.1111/jgh.12992.
    PubMed     Text format     Abstract available


  42. MARUYAMA H, Kondo T, Kiyono S, Sekimoto T, et al
    Relationship and interaction between serum sodium concentration and portal hemodynamics in patients with cirrhosis.
    J Gastroenterol Hepatol. 2015 May 13. doi: 10.1111/jgh.13006.
    PubMed     Text format     Abstract available


  43. BUCSICS T, Mandorfer M, Schwabl P, Bota S, et al
    Impact of acute kidney injury on prognosis of patients with liver cirrhosis and ascites: a retrospective cohort study.
    J Gastroenterol Hepatol. 2015 May 13. doi: 10.1111/jgh.13002.
    PubMed     Text format     Abstract available


    April 2015
  44. JUNKER AE, Gluud LL, Holst JJ, Knop FK, et al
    Influence of gastrointestinal factors on glucose metabolism in patients with cirrhosis.
    J Gastroenterol Hepatol. 2015 Apr 13. doi: 10.1111/jgh.12981.
    PubMed     Text format     Abstract available


  45. MOHAMMED OK, Mahadeva S
    Clinical outcomes of cryptogenic compared to non-cryptogenic cirrhosis: A retrospective cohort study.
    J Gastroenterol Hepatol. 2015 Apr 13. doi: 10.1111/jgh.12978.
    PubMed     Text format     Abstract available


  46. KHOKHAR N, Qureshi MO, Ahmad S, Ahmad A, et al
    Comparison of once a day rifaximin to twice a day dosage in prevention of recurrence of hepatic encephalopathy in patients with chronic liver disease.
    J Gastroenterol Hepatol. 2015 Apr 13. doi: 10.1111/jgh.12970.
    PubMed     Text format     Abstract available


  47. JIA J, Hou J, Ding H, Chen G, et al
    Transient elastography compared to serum markers to predict liver fibrosis in a cohort of Chinese patients with chronic hepatitis B.
    J Gastroenterol Hepatol. 2015;30:756-62.
    PubMed     Text format     Abstract available


  48. CAVIGLIA GP, Sciacca C, Abate ML, Olivero A, et al
    Chronic hepatitis C virus infection and lymphoproliferative disorders: mixed cryoglobulinemia syndrome, monoclonal gammopathy of undetermined significance, and B-cell non-Hodgkin lymphoma.
    J Gastroenterol Hepatol. 2015;30:742-7.
    PubMed     Text format     Abstract available


  49. SHI Y, Zheng MH, Yang Y, Wei W, et al
    Increased delayed mortality in patients with acute-on-chronic liver failure who have prior decompensation.
    J Gastroenterol Hepatol. 2015;30:712-8.
    PubMed     Text format     Abstract available


    March 2015
  50. LEE SS, Jeong SH, Jang ES, Kim YS, et al
    A prospective cohort study on the outcomes of hepatitis C virus-related cirrhosis in South Korea.
    J Gastroenterol Hepatol. 2015 Mar 16. doi: 10.1111/jgh.12950.
    PubMed     Text format     Abstract available


  51. ABE H, Aida Y, Seki N, Sugita T, et al
    Aldehyde dehydrogenase 2 polymorphism influences development to hepatocellular carcinoma in East Asian alcoholic liver cirrhosis.
    J Gastroenterol Hepatol. 2015 Mar 16. doi: 10.1111/jgh.12948.
    PubMed     Text format     Abstract available


  52. GIANNINI EG, Afdhal NH, Sigal SH, Muir AJ, et al
    Non-cirrhotic thrombocytopenic patients with hepatitis C virus: characteristics and outcome of antiviral therapy.
    J Gastroenterol Hepatol. 2015 Mar 16. doi: 10.1111/jgh.12942.
    PubMed     Text format     Abstract available


  53. CHAN AW, Chan RC, Wong GL, Wong VW, et al
    A new simple prognostic score for primary biliary cirrhosis: Albumin-Bilirubin (ALBI) score.
    J Gastroenterol Hepatol. 2015 Mar 9. doi: 10.1111/jgh.12938.
    PubMed     Text format     Abstract available


  54. KEMP W, Levy M, Weltman M, Lubel J, et al
    Australian Liver Association (ALA) expert consensus recommendations for the use of transient elastography in chronic viral hepatitis.
    J Gastroenterol Hepatol. 2015;30:453-62.
    PubMed     Text format     Abstract available


  55. WONG GL, Chan HL, Yu Z, Wong CK, et al
    Noninvasive assessments of liver fibrosis with transient elastography and Hui index predict survival in patients with chronic hepatitis B.
    J Gastroenterol Hepatol. 2015;30:582-90.
    PubMed     Text format     Abstract available


  56. AGRAWAL S, Duseja A, Gupta T, Dhiman RK, et al
    Simple organ failure count versus CANONIC grading system for predicting mortality in acute-on-chronic liver failure.
    J Gastroenterol Hepatol. 2015;30:575-81.
    PubMed     Text format     Abstract available


  57. DING H, Ma JJ, Wang WP, Zeng WJ, et al
    Assessment of liver fibrosis: the relationship between point shear wave elastography and quantitative histological analysis.
    J Gastroenterol Hepatol. 2015;30:553-8.
    PubMed     Text format     Abstract available


  58. YANG Y, Zhao Z, Liu Y, Kang X, et al
    Suppression of oxidative stress and improvement of liver functions in mice by ursolic acid via LKB1-AMP-activated protein kinase signaling.
    J Gastroenterol Hepatol. 2015;30:609-18.
    PubMed     Text format     Abstract available


    February 2015
  59. TOYODA H, Kumada T, Tada T, Kiriyama S, et al
    Risk Factors of HCC Development in Non-cirrhotic Patients with Sustained Virologic Response for Chronic HCV Infection.
    J Gastroenterol Hepatol. 2015 Feb 13. doi: 10.1111/jgh.12915.
    PubMed     Text format     Abstract available


  60. MAAN R, van der Meer AJ, Hansen BE, Feld JJ, et al
    Risk of infections during interferon-based treatment in patients with chronic HCV infection and advanced hepatic fibrosis.
    J Gastroenterol Hepatol. 2015 Feb 13. doi: 10.1111/jgh.12929.
    PubMed     Text format     Abstract available


  61. CENGIZ M, Ozenirler S, Elbeg S
    The role of serum toll-like receptors 2 and 4 in nonalcoholic steatohepatitis and liver fibrosis.
    J Gastroenterol Hepatol. 2015 Feb 13. doi: 10.1111/jgh.12924.
    PubMed     Text format     Abstract available


  62. LIN MT, Chang KC, Chou YP, Tseng PL, et al
    The validation of the 2010 American Association for the Study of Liver Diseases guideline for the diagnosis of hepatocellular carcinoma in an endemic area.
    J Gastroenterol Hepatol. 2015;30:345-51.
    PubMed     Text format     Abstract available


  63. SINCLAIR M, Grossmann M, Gow PJ, Angus PW, et al
    Testosterone in men with advanced liver disease: abnormalities and implications.
    J Gastroenterol Hepatol. 2015;30:244-51.
    PubMed     Text format     Abstract available


    January 2015
  64. DONG R, Zheng S
    Interleukin-8: A critical chemokine in biliary atresia.
    J Gastroenterol Hepatol. 2015 Jan 22. doi: 10.1111/jgh.12900.
    PubMed     Text format     Abstract available


  65. TANG WP, Akahoshi T, Piao JS, Narahara S, et al
    Basic FGF-treated adipose tissue-derived mesenchymal stem cell infusion ameliorate liver cirrhosis via paracrine HGF.
    J Gastroenterol Hepatol. 2015 Jan 16. doi: 10.1111/jgh.12893.
    PubMed     Text format     Abstract available


  66. WANG CC, Tseng TC, Kao JH
    Hepatitis B virus infection and metabolic syndrome: fact or fiction?
    J Gastroenterol Hepatol. 2015;30:14-20.
    PubMed     Text format     Abstract available


    December 2014
  67. QU K, Yan Z, Wu Y, Chen Y, et al
    Transarterial chemoembolization aggravated peritumoral fibrosis via HIF-1alpha dependent pathway in hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2014 Dec 30. doi: 10.1111/jgh.12873.
    PubMed     Text format     Abstract available


    November 2014
  68. HOWELL J, Van Gemert C, Lemoine M, Thursz M, et al
    Overview of hepatitis B prevalence, prevention, and management in the Pacific Islands and Territories.
    J Gastroenterol Hepatol. 2014;29:1854-66.
    PubMed     Text format     Abstract available


    October 2014
  69. KIM SH, Keum B, Kim ES, Jeen YT, et al
    Hepatobiliary and Pancreatic: Caput Medusae.
    J Gastroenterol Hepatol. 2014 Oct 10. doi: 10.1111/jgh.12802.
    PubMed     Text format    


    September 2014
  70. OGAWA E, Furusyo N, Nakamuta M, Kajiwara E, et al
    Efficacy and safety of splenectomy in telaprevir-based triple therapy for chronic hepatitis C patients with thrombocytopenia and advanced fibrosis.
    J Gastroenterol Hepatol. 2014;29:1728-35.
    PubMed     Text format     Abstract available


  71. AVIHINGSANON A, Jitmitraparp S, Tangkijvanich P, Ramautarsing RA, et al
    Advanced liver fibrosis by transient elastography, fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: role of vitamin D levels.
    J Gastroenterol Hepatol. 2014;29:1706-14.
    PubMed     Text format     Abstract available


    August 2014
  72. SOBBE A, Bridle KR, Jaskowski L, de Guzman CE, et al
    Inconsistent hepatic antifibrotic effects with the iron chelator Deferasirox.
    J Gastroenterol Hepatol. 2014 Aug 28. doi: 10.1111/jgh.12720.
    PubMed     Text format     Abstract available


  73. SIEVERT W, Razavi H, Estes C, Thompson AJ, et al
    Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia.
    J Gastroenterol Hepatol. 2014;29 Suppl 1:1-9.
    PubMed     Text format     Abstract available


    June 2014
  74. GOEL A, Gupta M, Aggarwal R
    Gut microbiota and liver disease.
    J Gastroenterol Hepatol. 2014;29:1139-48.
    PubMed     Text format     Abstract available


    May 2014
  75. DELLA CORTE C, Nobili V, Comparcola D, Cainelli F, et al
    Management of chronic hepatitis B in children: an unresolved issue.
    J Gastroenterol Hepatol. 2014;29:912-9.
    PubMed     Text format     Abstract available


  76. PARK YH, Kim BK, Kim JK, Kim HC, et al
    Long-term outcomes of chronic hepatitis B virus infection in the era of antiviral therapy in Korea.
    J Gastroenterol Hepatol. 2014;29:1005-11.
    PubMed     Text format     Abstract available


    January 2014
  77. KITSON MT, George J, Dore GJ, Leung R, et al
    Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection.
    J Gastroenterol Hepatol. 2014;29:1458-62.
    PubMed     Text format     Abstract available


    December 2013
  78. TORIGUCHI K, Hatano E, Tanabe K, Takemoto K, et al
    CHOP deficiency attenuates steatohepatitis, fibrosis and carcinogenesis in mice fed an MCD diet.
    J Gastroenterol Hepatol. 2013 Dec 11. doi: 10.1111/jgh.12481.
    PubMed     Text format     Abstract available


    November 2013
  79. CHEN S , Teoh NC, Chitturi S, Farrell GC, et al
    Coffee and Non-Alcoholic Fatty Liver Disease: Brewing evidence for hepatoprotection?
    J Gastroenterol Hepatol. 2013 Nov 7. doi: 10.1111/jgh.12422.
    PubMed     Text format     Abstract available


    October 2013
  80. ZHANG D, Zhang J, Jiang X, Li X, et al
    Heparin-binding EGF-like growth factor promotes proliferation via activating ErbB receptors in hepatic stellate cells.
    J Gastroenterol Hepatol. 2013 Oct 21. doi: 10.1111/jgh.12412.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: